Financial & Business, OEM News, Supplier News

2024 Medical Device Manufacturing M&A Roundup (Updated 12/23)

A quick reference of all the mergers and acquisitions that took place within the medical device manufacturing space (suppliers and OEMs) in 2024.

Author Image

By: Sean Fenske

Editor-in-Chief

Consolidation between suppliers or medical device OEMs have become commonplace. The industry’s landscape is in a constant state of flux as specialized firms are absorbed by a peer organization. The factors driving this trend are numerous, and the outcomes enable access to new technologies, customers, regions, and/or capabilities.

Given how prominent these deals are within the medical device manufacturing community, this page will be a dedicated resource to provide a quick-glance utility to all the transactions that take place within 2024. Return often to stay abreast of the latest deals occurring within the industry and get a brief recap of the most important details.

Safe Life—D-Sécurité Groupe

D-Sécurité is a French supplier of AEDs and medical equipment. The company has built a strong reputation in AED sale and distribution, as well as related medical equipment.
Date of Announcement: December 23, 2024
Value: Not disclosed
More info

Siemens Healthineers—Advanced Accelerator Applications Molecular Imaging from Novartis

Siemens Healthineers completed the acquisition of the Advanced Accelerator Applications Molecular Imaging business from Novartis. The transaction includes the business’s established manufacturing and distribution network, its workforce, product portfolio, and developer relationships.
Date of Announcement: December 10, 2024
Value: Not disclosed
More info

GE HealthCare—Nihon Medi-Physics

GE-HealthCare will gain the remaining 50% stake in Japanese radiopharmaceutical company Nihon Medi-Physics. NMP can build on its expertise in developing and manufacturing proprietary and in-licensed radiopharmaceuticals.
Date of Announcement: December 3, 2024
Value: Not disclosed
More info

SyntheticMR—Combinostics

SyntheticMR agreed to acquire Combinostics Oy, a Finnish medical technology and software solutions company, focusing on cloud-based and AI-driven platforms that offer advanced diagnostic tools and clinical decision support for healthcare providers. 
Date of Announcement: December 2, 2024
Value: €4.3 million
More info

Boston Scientific—Intera Oncology

Intera Oncology is a privately held company that offers the Intera 3000 hepatic artery infusion pump and chemo drug floxuridine, both of which are U.S. Food and Drug Administration (FDA) approved.
Date of Announcement: November 25, 2024
Value: Not disclosed
More info

Arlington Capital Partners—TEAM Technologies

TEAM Tech is a provider of specialized manufacturing and strategic supply chain solutions to blue-chip healthcare customers and offers end-to-end outsourced design and manufacturing services to medical device and pharmaceutical OEMs.
Date of Announcement: November 25, 2024
Value: Not disclosed
More info

Henry Schein—Acentus

Acentus is a medical supplier that specializes in delivery of continuous glucose monitors. It boasts annual revenue of about $35 million and is headquartered in Tampa, Fla. 
Date of Announcement: November 19, 2024
Value: Not disclosed
More info

Nihon Kohden—Ad-Tech Medical Instrument Corp.

Nihon Kohden acquired a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation. This strengthens Nihon Kohden’s epilepsy diagnostics and care.
Date of Announcement: November 12, 2024
Value: Not disclosed
More info

Vance Street Capital—Prince Sterilization Services

Vance Street Capital acquired Prince Sterilization to help support Prince Sterilization’s growth in the medical device and pharmaceutical markets.
Date of Announcement: November 7, 2024
Value: Not disclosed
More info

Boston Scientific—Cortex

Boston Scientific has agreed to acquire Cortex, a privately held medical technology company. With this Boston Scientific gains Cortex’s FDA-cleared OptiMap System.
Date of Announcement: November 4, 2024
Value: Not disclosed
More info

BioSig—Neuro-Kinesis Corp.

NKC’s patented, catheter-based diagnostic system aims to address the limitations of electrophysiology mapping. The components of this system include the Huygens catheter and Proteus robotic arm.
Date of Announcement: July 31, 2024
Value: Not disclosed
More info

Stryker—MOLLI Surgical

MOLLI is a privately-held company that specializes in wire-free, soft tissue localization technology for breast-conserving surgery.
Date of Announcement: July 31, 2024
Value: Not disclosed
More info

Linus Health—Together Senior Health

Together Senior Health is a brain health company delivering evidence-based solutions for individuals with cognitive decline, Alzheimer’s disease, and related dementias. The comapny will operate as a wholly owned subsidary of Linus Health
Date of Announcement: July 26, 2024
Value: Not disclosed
More info

Edwards Lifesciences—JenaValve & Endotronix

JenaValve is a pioneer in transcatheter treatment for aortic regurgitation and developer of the Trilogy heart valve system. Endotronix is a developer of heart failure management solutions and maker of the Cordella pulmonary artery sensor.
Date of Announcement: July 25, 2024
Value: $1.2 billion
More info

GE HealthCare—Intelligent Ultrasound’s Clinical AI Biz

Intelligent Ultrasound’s AI-driven image analysis tools were designed to make ultrasound smarter and boost its efficiency.
Date of Announcement: July 18, 2024
Value: $51 million
More info

Edwards Lifesciences—Innovalve

Innovalve is an early-stage transcatheter mitral valve replacement (TMVR) company. Edwards initially invested in Innovalve in 2017.
Date of Announcement: July 15, 2024
Value: Not disclosed
More info

Alcon—Belkin Vision

Belkin is the maker of direct selective laser trabeculoplasty (DLST) technology, a primary treatment for open-angle glaucoma and ocular hypertension. DLST can effectively lower intraocular pressure.
Date of Announcement: July 2, 2024
Value: up to $385 million ($81 million upfront, remaining balance depends on sales-based milestones)
More info

Merit Medical Systems—EndoGastric Solutions’ EsophyX Z+ device

The EsophyX Z+ device is used in an endoscopic procedure called transoral incisionless fundoplication (TIF 2.0) to treat gastroesophageal reflux disorder (GERD).
Date of Announcement: July 1, 2024
Value: $105 million
More info

DuPont—Donatelle

Donatelle is a contract manufacturer that specializes in design, development, and manufacture of medical components and devices for electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities. The company adds injection molding, liquid silicone rubber (LSR) processing, precision machining, assembly, and tool building capabilities to DuPont’s growing medtech business.
Date of Announcement: June 25, 2024 (closed July 29, 2024)
Value: Not disclosed
More info

Battery Ventures—steute Technologies

steute adds manufacturing capabilities for switches, sensors, and control units for medical and industrial application to the company’s arsenal.
Date of Announcement: June 19, 2024
Value: Not disclosed
More info

Boston Scientific—Silk Road Medical

Silk Road Medical adds a platform of products to prevent stroke in carotid artery disease patients via a minimally invasive procedure called transcarotid artery revascularization (TCAR) to Boston Scientific’s offering.
Date of Announcement: June 18, 2024
Value: $27.50 per share (~1.16 billion)
More info

KARL STORZ—Asensus Surgical

The U.S. subsidiary of the independent, family-owned KARL STORZ SE & Co. KG will merge with Asensus, enhancing its position in the growing robotic surgical market.
Date of Announcement: June 7, 2024
Value: $0.35 per share (~67% premium NYSE price at April 2)

BD—Edwards Lifesciences’ Critical Care business

The portfolio includes the Swan Ganz pulmonary artery catheter, minimally invasive sensors, noninvasive cuffs, tissue oximetry sensors, and monitors. Edwards pursued this route instead of a December 2023 announcement to spin off the hemodynamic monitoring business.
Date of Announcement: June 3, 2024
Value: $4.2 billion (all cash)

WACKER—Bio Med Sciences

WACKER has positioned itself as a provider of silicone-coated products with the acquisition of Bio Med Sciences. The deal includes a majority of the company and its workforce wich will relocate and be named to Wacker Silicone Manufactured Innovations LLC (WSMI).
Date of Announcement: May 31, 2024
Value: Not disclosed
More info

Veranex—HORUS Scientific

HORUS Scientific’s North American capability complements Veranex’s in-house pathology and histology services in Paris, fortifying the company’s pathology service line.
Date of Announcement: May 1, 2024
Value: Not disclosed
More info

Radformation—Limbus AI

Radformation, a developer of automation solutions for cancer care, acquired privately-held Limbus AI, a provider of automated contouring software for radiation therapy.
Date of Announcement: May 1, 2024
Value: Not disclosed
More info

Medline—Ecolab’s Global Surgical Solutions Business

The acquisition will provide Medline with sterile drape solutions for surgeons, patients, and operating room equipment. It will also add Ecolab’s fluid temperature management system to its portfolio.
Date of Announcement: April 30, 2024 (completed August 1, 2024)
Value: Not disclosed
More info

Hologic—Endomagnetics

Cambridge, U.K.-based Endomagnetics offers breast surgery localization and lymphatic tracing technologies, has been acquired by Hologic.
Date of Announcement: April 29, 2024 (completed July 25, 2014)
Value: $310 million
More info

Solar Atmospheres—Certified Metal Craft Inc.

Solar Atomspheres has acquired San Diego-based Certified Metal Craft Inc. (CMC). CMC establishes Solar’s 6th nationwide location and bolsters its West Coast presence.
Date of Announcement: April 29, 2024
Value: Not disclosed
More info

STERIS Dental Segment—Peak Rock Capital

STERIS entered a definitive agreement to sell its Dental division to Peak Rock Capital private investment firm. STERIS might also receive an additional earn out of up to $12.5 million, subject to revenue targets of the Dental segment in fiscal 2025.
Date of Announcement: April 11, 2024
Value: $787.5 million
More info

Johnson & Johnson—Shockwave Medical

J&J will acquire all outstanding Shockwave Medical shares for $335 per share in cash. Shockwave is the first-to-market provider of intravascular lithotripsy (IVL) tech to treat calcified CAD and PAD.
Date of Announcement: April 5, 2024
Value: $13.1 billion
More info

Wytech Industries—Silvertip & Associates

Wytech Industries has acquired the assets to Silvertip & Associates, a metal finishing company located in Minneapolis, MN. With this acquisition Wytech expands its precision grinding capabilites.
Date of Announcement: April 1, 2024
Value: Not disclosed
More info

Medical Technology and Devices (MTD)—Ypsomed

MTD began a deal to acquire Ypsomed’s pen needle and blood glucose monitoring businesses. The acquisition allows MTD to open new, strategic markets like Germany.
Date of Announcement: March 27, 2024
Value: Not disclosed
More info

Johnson Matthey—Montagu Private Equity

Johnson Matthey began an agreement to sell its Medical Device Components (MDC) business to Montagu. The company’s MDC business produces components for medical device manufacturers globally, with emphasis on precious metal alloys and nitinol.
Date of Announcement: March 20, 2024
Value: £550 million ($700 million)
More info

DirectMed Imaging—Titanium Medical Imaging

DirectMed Imaging has acquired Houston, TX-based Titanium Medical Imaging company. DirectMed Imaging can now offer customers around the world with immediate access to mission-critical inventory for all four major original equipment manufacturers (OEM), with expanded engineer training to include Canon/Toshiba MRI and CT equipment.
Date of Announcement: March 18, 2024
Value: Not disclosed
More info

Titan Medical—Conavi Medical

Titan and Conavi Medical have agreed to merge in an all-stock transaction. Titan will acquire all issued and outstanding Conavi shares, and Conavi shareholders will be issued common shares of Titan. The transaction will constitute a reverse takeover of Titan.
Date of Announcement: March 18, 2024
Value: Not disclosed
More info

Novanta—Motion Solutions

Novanta Inc. has completed its $189 million acquisition of Motion Solutions. With this Novanta adds complementary motion subsystem solutions to the company’s product portfolio.
Date of Announcement: March 13, 2024
Value: $189 million
More info

Olympus—Taewoong Medical (RESCINDED)

After announcing the closing of the $370 million deal for Taewoong Medical on January 24, Olympus rescinded the acquisition on March 7 after discovering “data integrity issues” related to Taewoong products.
Date of Announcement: March 7, 2024

Haemonetics—Attune Medical

The company began a deal to acquire Attune, maker of the ensoETM proactive esophageal cooling device, which offers esophageal protection during radiofrequency (RF) ablation.
Date of Announcement: March 5, 2024
Value: $160 million
More info

AngioDynamics—Spectrum Vascular

AngioDynamics sold its PICC, Midline, and tip location products to Spectrum Vascular. The combined portfolio generated about $43.5 million in annual sales during the company’s fiscal year 2023.
Date of Announcement: February 16, 2024
Value: Up to $45 million
More info

Trelleborg Sealing Solutions—Barron Group

Trelleborg Group has signed an agreement to acquire Baron Group advanced silicone components manufacturer through its Trelleborg Sealing Solutions business area,
Date of Announcement: February 6, 2024
Value: $300 million on a cash and debt-free basis.
More info

C2Dx—Cook Medical’s Otolaryngology/Head and Neck Surgery (OHNS) Products

Shore Capital Partners partnered with C2Dx medical device company, has acquired Otolaryngology/Head and Neck Surgery (OHNS) products from Cook Medical.
Date of Announcement: January 29, 2024
Value: Not disclosed
More info

Arterex—Micromold

Arterex, a leading medical device developer and contact manufacturer, has acquired Micromold, Inc. The company is a supplier of custom precision micromolded parts to the medical industry.
Date of Announcement: January 24, 2024
Value: Not disclosed
More info

Cynosure—Lutronic

Lutronic adds intelligent laser and energy-based systems to Cynosure’s portfolio. The company has products for skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring.
Date of Announcement: January 19, 2024
Value: Not disclosed
More info

Kindeva Drug Delivery—Summit Biosciences

Summit is an intranasal drug-delivery contract development and manufacturing organization (CDMO) and adds a 55,000-square-foot cGMP facility to Kindeva’s nine existing facilities.
Date of Announcement: January 18, 2024
Value: Not disclosed
More info

CardioFocus—Galvanize Therapeutics’ Electrophysiology Division

Included in the acquisition is the Centauri pulsed electric field generator, which has EU approval and is commercially available in the EU and U.K.
Date of Announcement: January 11, 2024
Value: Not disclosed
More info

Integer Holdings—Pulse Technologies

Medical device outsource manufacturer Integer Holdings closed the acquisition of Pulse Technologies, an engineering and contract manufacturing firm that focuses on complex micro machining of components for structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation devices.
Date of Announcement: January 10, 2024 (acquisition closed January 5)
Value: $140 million
More info

GE HealthCare—MIM Software

GE HealthCare entered an agreement to acquire MIM Software, a provider of medical imaging analysis and artificial intelligence solutions for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology.
Date of Announcement: January 8, 2024 (acquisition closed April 1)
Value: Not disclosed
More info

Boston Scientific—Axonics

Boston Scientific began a deal to acquire Axonics for a purchase price of $71 per share. Axonics focuses primarily on devices to treat urinary and bowel dysfunction.
Date of Announcement: January 8, 2024
Value: $3.7 billion
More info

Roche—LumiraDx’s Point-of-Care

Roche began a deal to acquire certain parts of the LumiraDx group that are related to the company’s Point of Care technology. The transaction is expected to close by mid-2024, at which point the acquired businesses will be integrated into Roche Diagnostics.
Date of Announcement: January 2, 2024
Value: $295 million at closing (with an additional $55 million payment to reimburse amounts to fund the POC business until the acquisition’s closing)
More info

Probo Medical—Alpha Source Group

Probo Medical—a provider of medical imaging equipment, parts, repair, and service—began a deal to acquire Alpha Source Group to expand its diagnostic imaging solutions platform.
Date of Announcement: January 2, 2024
Value: Not disclosed
More info

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters